Spectral Genomics Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $14M

Spectral Genomics General Information

Description

Developer and marketer of products and services in molecular genetics and diagnostics. The company also provides genomic profiling services for customers in academic and industrial research laboratories.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 8080 North Stadium Drive
  • Suite 2200
  • Houston, TX 77054
  • United States
+1 (713)
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Acquirer
Vertical(s)
Corporate Office
  • 8080 North Stadium Drive
  • Suite 2200
  • Houston, TX 77054
  • United States
+1 (713)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Spectral Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 01-Apr-2006 $14M Completed Clinical Trials - Phase 3
4. Early Stage VC (Series B) 15-Mar-2004 Completed Clinical Trials - Phase 3
3. Early Stage VC (Series A) 01-Aug-2001 Completed Startup
2. Accelerator/Incubator Completed Startup
1. University Spin-Out 01-Jan-2000 Completed Startup
To view Spectral Genomics’s complete valuation and funding history, request access »

Spectral Genomics Patents

Spectral Genomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2004262040-A1 Arrays, methods and kits for preparation and use of syntenic genomic arrays for diagnostics and toxicology Inactive 01-Aug-2003
WO-2005012500-A2 Arrays, methods and kits for preparation and use of syntenic genomic arrays for diagnostics and toxicology Inactive 01-Aug-2003
WO-2005012500-A3 Arrays, methods and kits for preparation and use of syntenic genomic arrays for diagnostics and toxicology Inactive 01-Aug-2003
AU-2003220159-A1 Articles of manufacture and methods for making hydrophobic derivatized arrays Inactive 08-Mar-2002
AU-2003220159-A8 Articles of manufacture and methods for making hydrophobic derivatized arrays Inactive 08-Mar-2002 G01N33/552
To view Spectral Genomics’s complete patent history, request access »

Spectral Genomics Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
BCM Ventures Venture Capital Minority
Baylor College of Medicine University Minority
BioTex Finance Venture Capital Minority
Burrill & Co Merchant Banking Firm Minority
Houston Technology Center Accelerator/Incubator Minority
You’re viewing 5 of 7 investors. Get the full list »

Spectral Genomics Acquisitions (1)

Spectral Genomics’s most recent deal was a Merger/Acquisition with Bacterial BarCodes. The deal was made on 15-Mar-2004.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Bacterial BarCodes 15-Mar-2004 Merger/Acquisition Other Healthcare Technology Systems
To view Spectral Genomics’s complete acquisitions history, request access »

Spectral Genomics FAQs

  • When was Spectral Genomics founded?

    Spectral Genomics was founded in 2000.

  • Where is Spectral Genomics headquartered?

    Spectral Genomics is headquartered in Houston, TX.

  • What industry is Spectral Genomics in?

    Spectral Genomics’s primary industry is Biotechnology.

  • Is Spectral Genomics a private or public company?

    Spectral Genomics is a Private company.

  • What is the current valuation of Spectral Genomics?

    The current valuation of Spectral Genomics is .

  • What is Spectral Genomics’s current revenue?

    The current revenue for Spectral Genomics is .

  • How much funding has Spectral Genomics raised over time?

    Spectral Genomics has raised $12.3M.

  • Who are Spectral Genomics’s investors?

    BCM Ventures, Baylor College of Medicine, BioTex Finance, Burrill & Co, and Houston Technology Center are 5 of 7 investors who have invested in Spectral Genomics.

  • When was Spectral Genomics acquired?

    Spectral Genomics was acquired on 01-Apr-2006.

  • Who acquired Spectral Genomics?

    Spectral Genomics was acquired by Revvity.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process